Troy Cox is Director of SomaLogic, Inc.. Currently has a direct ownership of 0 shares of SLGC, which is worth approximately $0. The most recent transaction as insider was on Jan 05, 2024, when has been sold 78,430 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Troy Cox Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2024
SELL
Sale (or disposition) back to the issuer
-
78,430 Reduced 100.0%
0 Common Stock
Mar 17 2023
BUY
Grant, award, or other acquisition
-
28,500 Added 21.04%
106,930 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
3,430 Added 4.19%
78,430 Common Stock
Sep 01 2021
BUY
Grant, award, or other acquisition
$500,000 $10.0 p/Share
50,000 Added 40.0%
75,000 Class A Common Stock
Sep 01 2021
BUY
Other acquisition or disposition
-
25,000 Added 50.0%
25,000 Class A Common Stock

Also insider at

ZYME
Zymeworks Inc. Healthcare
LAB
STANDARD BIOTOOLS INC. Healthcare
ZYME
Zymeworks Inc.
TC

Troy Cox

Director
Cambridge, MA

Track Institutional and Insider Activities on SLGC

Follow SomaLogic, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLGC shares.

Notify only if

Insider Trading

Get notified when an Soma Logic, Inc. insider buys or sells SLGC shares.

Notify only if

News

Receive news related to SomaLogic, Inc.

Track Activities on SLGC